347
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Effect of vehicle systems, pH and enhancers on the permeation of highly lipophilic aripiprazole from Carbopol 971P gel systems across human cadaver skin

, &
Pages 323-330 | Received 15 Apr 2011, Accepted 29 Jun 2011, Published online: 08 Nov 2011

References

  • Aggarwal G, Dhawan S. (2010). Psychotropic Drugs and transdermal Delivery: An Overview. International J of Pharma and Bio Science, 1 (2),
  • Chein YW. Novel Drug Delivery systems. New York: Marcel Dekker, Inc; 1992: 1–42.
  • Wiechers JW. (1989). The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm Weekbl Sci, 11:185–198.
  • Arellano A, Santoyo S, Martín C, Ygartua P. (1999). Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels. Eur J Pharm Sci, 7:129–135.
  • Subedi RK, Oh SY, Chun MK, Choi HK. (2010). Recent advances in transdermal drug delivery. Arch Pharm Res, 33:339–351.
  • Marjukka Suhonen T, Bouwstra JA, Urtti A. (1999). Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release, 59:149–161.
  • Kim JJ, Chi SC, Shim CK, Kim CK. (1992). Effect of Tween 20 on the penetration of ketoprofen through excised rat skin. J Kor Pharm Sci, 22:163–166.
  • Kim CK, Kim JJ, Chi SC, Shim CK. (1993). Effect of fatty acids and urea on the penetration of ketoprofen through rat skin. Int J Pharm, 99:109–118.
  • Lee CK, Uchida T, Noguchi E, Kim NS, Goto S. (1993). Skin permeation enhancement of tegafur by ethanol/panasate 800 or ethanol/water binary vehicle and combined effect of fatty acids and fatty alcohols. J Pharm Sci, 82:1155–1159.
  • Carelli V, Di Colo G, Nannipieri E, Serafini MF. (1998). Effect of vehicles on yohimbine permeation across excised hairless mouse skin. Pharm Acta Helv, 73:127–134.
  • Otto A, Wiechers JW, Kelly CL, Hadgraft J, du Plessis J. (2008). Effect of penetration modifiers on the dermal and transdermal delivery of drugs and cosmetic active ingredients. Skin Pharmacol Physiol, 21:326–334.
  • Adrian PF, Roman S, Hans WM, Clemens G, Rainer HM, Ralph L. Transdermal delivery of highly lipophilic drugs: In vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations. Pharmaceutical Research, Vol. 19, No. 5, May 2002.
  • Chisty MNA, Plakogiannis MF, Bellantone RA, Taft DR. “In vitro evaluation of the release of albuterol sulfate from polymer gels: Effect of fatty acids on drug transport across biological membranes”. Drug Development and Industrial Pharmacy, Vol 28, No. 10, pp. 1221–1229, 2002.
  • Narisetty ST, Ramesh P. (2003). Transdermal delivery of zidovudine: Effect of vehicles on permeation across rat skin and their mechanism of action. European J of Pharmaceutical Sciences, 18:71–79.
  • Ostrenga J, Haleblian J, Poulsen B, Ferrell B, Mueller N, Shastri S. (1971). Vehicle design for a new topical steroid, fluocinonide. J Invest Dermatol, 56:392–399.
  • Møllgaard B, Hoelgaard A. (1983). Vehicle effect on topical drug delivery. II. Concurrent skin transport of drugs and vehicle components. Acta Pharm Suec, 20:443–450.
  • Han-Joon O, Yu-Kyoung O, Chong-Kook K. (2001). Effects of vehicles and enhancers on transdermal delivery of melatonin. Int J Pharm, 212:63–71.
  • Seyed AM, Reza A. (2003). An investigation into the effect of various penetration enhancers on percutaneous absorption of piroxicam. Iranian J Pharm Research, 2:135–140.
  • Sato A, Friend O, Nagai I. (1988). Effect and mode of action of aliphatic esters. Int J Pharm, 43:31–40.
  • Sasaki H, Kojima M, Nakamura J, Shibasaki J. (1990). Enhancing effect of combining two pyrrolidone vehicles on transdermal drug delivery. J Pharm Pharmacol, 42:196–199.
  • Phillips CA, Michniak BB. (1995). Transdermal delivery of drugs with differing lipophilicities using azone analogs as dermal penetration enhancers. J Pharm Sci, 84:1427–1433.
  • Sinha VR, Kaur MP. (2000). Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm, 26:1131–1140.
  • Asbill CS, El-Kattan AF, Michniak B. (2000). Enhancement of transdermal drug delivery: Chemical and physical approaches. Crit Rev Ther Drug Carrier Syst, 17:621–658.
  • Kenneth AW, Keith RB, Darren MG, Valerie JJ, Adam CW, Robert HS. (1998). Comparison of the transdermal delivery of estradiol from two gel formulations. Maturitas, 29:189–195.
  • Williams AC. Transdermal and topical drug delivery. Lotion: Pharmaceutical Press; 2003.
  • Koizumi A, Fujii M, Kondoh M, Watanabe Y. (2004). Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur J Pharm Biopharm, 57:473–478.
  • Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev, 56:603–618.
  • Chantasart D, Sa-Nguandeekul P, Prakongpan S, Li SK, Higuchi WI. (2007). Comparison of the effects of chemical permeation enhancers on the lipoidal pathways of human epidermal membrane and hairless mouse skin and the mechanism of enhancer action. J Pharm Sci, 96:2310–2326.
  • Ogiso T, Paku T, Iwaki M, Tanino T. (1995). Percutaneous penetration of fluorescein isothiocyanate-dextrans and the mechanism for enhancement effect of enhancers on the intercellular penetration. Biol Pharm Bull, 18:1566–1571.
  • Goates CY, Knutson K. (1993). Enhanced permeation and stratum corneum structural alterations in the presence of dithiothreitol. Biochim Biophys Acta, 1153:289–298.
  • Ibrahim SA, Li SK. (2010). Efficiency of fatty acids as chemical penetration enhancers: Mechanisms and structure enhancement relationship. Pharm Res, 27:115–125.
  • Kandimalla K, Kanikkannan N, Andega S, Singh M. (1999). Effect of fatty acids on the permeation of melatonin across rat and pig skin in vitro and on the transepidermal water loss in rats in vivo. J Pharm Pharmacol, 51:783–790.
  • Aungst BJ. (1989). Structure/effect studies of fatty acid isomers as skin penetration enhancers and skin irritants. Pharm Res, 6:244–247.
  • Aungst BJ, Rogers NJ, Shefter E. (1986). Enhancement of naloxone penetration through human skin in vitro using fatty-acids, fatty alcohols, surfactants. sulfoxides and amides. Int J Pharm, 33:225–234.
  • Ongpipattanakul B, Burnette RR, Potts RO, Francoeur ML. (1991). Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm Res, 8:350–354.
  • Ogiso T, Shintani M. (1990). Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. J Pharm Sci, 79:1065–1071.
  • Elyan BM, Sidhom MB, Plakogiannis FM. (1996). Evaluation of the effect of different fatty acids on the percutaneous absorption of metaproterenol sulfate. J Pharm Sci, 85:101–105.
  • Pose-Vilarnovo B, Rodríguez-Tenreiro C, Rosa dos Santos JF, Vázquez-Doval J, Concheiro A, Alvarez-Lorenzo C et al. (2004). Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets. J Control Release, 94:351–363.
  • Wang YY, Hong CT, Chiu WT, Fang JY. (2001). In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int J Pharm, 224:89–104.
  • Das MK, Ahmed AB. (2007). Formulation and ex vivo evaluation of rofecoxib gel for topical application. Acta Pol Pharm, 64:461–467.
  • Zhou M, Donovan MD. (1996). Intranasal mucocilliary clearance of putative bioadhesive polymer gels. Int J Pharm, 135:115–125.
  • Shin SC, Kim HJ, Oh IJ, Cho CW, Yang KH. (2005). Development of tretinoin gels for enhanced transdermal delivery. Eur J Pharm Biopharm, 60:67–71.
  • Shin SC, Kim JY, Oh IJ. (2000). Mucoadhesive and physicochemical characterization of Carbopol-Poloxamer gels containing triamcinolone acetonide. Drug Dev Ind Pharm, 26:307–312.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.